Skip to content

Bruce E. Blough

19 papers in the library · 478 citations · publishing 2002-2026

Papers

Sort Most recent Most cited

Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.

ACS Pharmacology & Translational Science March 13, 2026 Bo Jarrett Wood, M Frances Vest, Catharine Carfagno et al.

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for mood and anxiety disorders, the same conditions under which psychedelic-assisted therapies are gaining renewed interest. However, it remains unclear how SSRI treatment may influence sensitivity to psychedelics, particularly through the shared engagement of serotonergic pathways. Here, we used the head-twitch response...

Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice.

ACS Chemical Neuroscience December 18, 2024 Grant C. Glatfelter, Allison A Clark, Natalie G. Cavalco et al. 14 citations

5-methoxy-N,N-dimethyltrytpamine (5-MeO-DMT) analogs are used as recreational drugs, but they are also being developed as potential medicines, warranting further investigation into their pharmacology. Here, we investigated the neuropharmacology of 5-MeO-DMT and several of its N-alkyl, N-allyl, and 2-methyl analogs, with three major aims: 1) to determine in vitro receptor profiles for the...

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 8, 2024 Jenny L Wiley, Julie A. Marusich, Bruce E. Blough et al.

The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Δ9-Tetrahydrocannabinol (Δ9-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Δ9-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used...

Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.

Frontiers in Cellular Neuroscience 2022 Charles Sutton, Erin Q Williams, Hoomam Homsi et al. 13 citations

Mutations in the dopamine transporter gene (SLC6A3) have been implicated in many human diseases. Among these is the infantile parkinsonism-dystonia known as Dopamine Transporter Deficiency Syndrome (DTDS). Afflicted individuals have minimal to no functional dopamine transporter protein. This is primarily due to retention of misfolded disease-causing dopamine transporter variants. This results...

DOI: 10.3389/fncel.2022.832536 (opens in new tab) Full text (opens in new tab) Ibogaine Bupropion Dopamine transporter dat Pharmacological chaperones +7

The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.

Psychopharmacology December 2020 Simon D. Brandt, Hailey M Walters, John S. Partilla et al.

The nonmedical use of new psychoactive substances (NPS) is a worldwide public health concern. The so-called "benzofury" compounds, 5-(2-aminopropyl)benzofuran (5-APB) and 6-(2-aminopropyl)benzofuran (6-APB), are NPS with stimulant-like properties in human users. These substances are known to interact with monoamine transporters and 5-HT receptors in transfected cells, but less is known about...

DOI: 10.1007/s00213-020-05648-z (opens in new tab) Full text (opens in new tab) Benzofury Designer drugs Locomotor activity MDMA, Mda +4

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice

Psychopharmacology July 15, 2019 Aboagyewaah Oppong‐Damoah, Kristen Curry, Bruce E. Blough et al.

Approximately 20 million adults in the USA have an alcohol use disorder (AUD). There are clinical and preclinical data suggesting that psychedelics may have benefits for AUD. To investigate the effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on the behavioral effects of ethanol. The effects of DOI were examined using ethanol-induced place conditioning (1.8 g/kg...

Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems

Journal of Psychopharmacology April 30, 2019 Dino Luethi, Karolina E. Kolaczynska, Melanie Walter et al. 39 citations

Background: Amphetamine analogs with a 3,4-methylenedioxy ring-substitution are among the most popular illicit drugs of abuse, exerting stimulant and entactogenic effects. Enzymatic N-demethylation or opening of the 3,4-methylenedioxy ring via O-demethylenation gives rise to metabolites that may be pharmacologically active. Indeed, previous studies in rats show that specific metabolites of...

The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes.

Psychopharmacology March 2019 Bruce E. Blough, Ann M Decker, Antonio Landavazo et al.

Novel synthetic "bath salt" cathinones continue to appear on the street as abused and addictive drugs. The range of subjective experiences produced by different cathinones suggests that some compounds have primarily dopaminergic activity (possible stimulants) while others have primarily serotonergic activity (possible empathogenics). An understanding of the structure activity relationships...

DOI: 10.1007/s00213-018-5063-9 (opens in new tab) Full text (opens in new tab) Biogenic amine transporters Methcathinones Rat brain synaptosomes “bath salts”

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Neuropharmacology November 1, 2018 Joshua S. Elmore, Ann M Decker, Agnieszka Sulima et al. 59 citations

2,5-Dimethoxyphenethylamines (2C compounds) are 5-HT2A/2C receptor agonists that induce hallucinogenic effects. N-methoxybenzylation of 2C compounds markedly increases their affinity for 5-HT2A receptors, and two such analogs, 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) and 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe),...

DOI: 10.1016/j.neuropharm.2018.02.033 (opens in new tab) Full text (opens in new tab) 5-ht2a receptor Back muscle contractions Wet dog shakes Nbome compounds nbome +8

Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family

Neuropharmacology October 12, 2017 Felix P. Mayer, Nadine V. Burchardt, Ann M Decker et al. 30 citations

A variety of new psychoactive substances (NPS) are appearing in recreational drug markets worldwide. NPS are compounds that target various receptors and transporters in the central nervous system to achieve their psychoactive effects. Chemical modifications of existing drugs can generate NPS that are not controlled by current legislation, thereby providing legal alternatives to controlled...

DOI: 10.1016/j.neuropharm.2017.10.006 (opens in new tab) Serotonin Monoamine neurotransmitter Pharmacology Amphetamine +6

The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.

Neuropharmacology February 2016 Julie A. Marusich, Kateland R Antonazzo, Bruce E. Blough et al.

In recent years, use of psychoactive synthetic stimulants has grown rapidly. 5-(2-Aminopropyl)indole (5-IT) is a synthetic drug associated with a number of fatalities, that appears to be one of the newest 3,4-methylenedioxymethamphetamine (MDMA) replacements. Here, the monoamine-releasing properties of 5-IT, its structural isomer 6-(2-aminopropyl)indole (6-IT), and MDMA were compared using in...

DOI: 10.1016/j.neuropharm.2015.09.004 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA 5-2-aminopropylindole 5-it 6-2-aminopropylindole 6-it Locomotor activity +2

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Psychopharmacology October 1, 2014 Bruce E. Blough, Antonio Landavazo, Ann M Decker et al. 99 citations

Synthetic hallucinogenic tryptamines, especially those originally described by Alexander Shulgin, continue to be abused in the USA. The range of subjective experiences produced by different tryptamines suggests that multiple neurochemical mechanisms are involved in their actions, in addition to the established role of agonist activity at serotonin 2A (5-HT₂A) receptors. This study evaluated the...

DOI: 10.1007/s00213-014-3557-7 (opens in new tab) Full text (opens in new tab) Hallucinogens Psychedelics Psychoactive substances Hallucinogenic compounds +12

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats

British Journal of Pharmacology October 12, 2013 Charles W. Schindler, Eric B. Thorndike, Bruce E. Blough et al. 35 citations

Background and Purpose The cardiovascular effects produced by 3,4‐methylenedioxymethamphetamine ( MDMA ; ‘ E cstasy’) contribute to its acute toxicity, but the potential role of its metabolites in these cardiovascular effects is not known. Here we examined the effects of MDMA metabolites on cardiovascular function in rats. Experimental Approach Radiotelemetry was employed to evaluate the...

DOI: 10.1111/bph.12423 (opens in new tab) MDMA Metabolite Pharmacology Antagonist +5

The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in “Bath Salts”

Journal of Addiction Research & Therapy December 1, 2012 Lucas R. Watterson, L. Hood, Kaveish Sewalia et al. 71 citations

Methylone is a member of the designer drug class known as synthetic cathinones which have become increasingly popular drugs of abuse in recent years. Commonly referred to as “bath salts”, these amphetamine-like compounds are sold as “legal” alternatives to illicit drugs such as cocaine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Following their dramatic rise in...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its metabolites on cardiovascular function in rats

The FASEB Journal April 1, 2012 Charles W. Schindler, Michael H Baumann, Eric B. Thorndike et al.

The abuse of MDMA (Ecstasy) peaked in the early 2000s, yet reports of MDMA use from emergency room admission data continue to increase. The potential for cardiovascular effects of MDMA to contribute to its acute toxicity has long been recognized. However, the role of MDMA metabolites in mediating the drug's cardiovascular actions has not been studied. Here we employed radiotelemetry to evaluate...

Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

European Journal of Pharmacology January 15, 2012 Samanta Yubero‐lahoz, Mario A Ayestas, Bruce E. Blough et al.

(±)-3,4-Methylenedioxymethamphetamine (MDMA) is an illicit drug that evokes transporter-mediated release of serotonin (5-HT) in the brain. 5-HT transporter (SERT) proteins are also expressed in non-neural tissues (e.g., blood), and evidence suggests that MDMA targets platelet SERT to increase plasma 5-HT. Here we tested two hypotheses related to the effects of MDMA on circulating 5-HT. First,...

Effects of “Legal X” Piperazine Analogs on Dopamine and Serotonin Release in Rat Brain

Annals of the New York Academy of Sciences October 1, 2004 Michael H. Baumann, Robert D. Clark, Allison G. Budzynski et al. 71 citations

3,4-Methylenedioxymethamphetamine (MDMA) is a popular illicit drug that evokes transporter-mediated release of serotonin (5-HT) and dopamine (DA) from nerve cells. Recently, drug users have ingested combinations of the piperazine analogs, 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP), in an attempt to mimic the subjective effects of MDMA. In the present study, we...

DOI: 10.1196/annals.1316.024 (opens in new tab) MDMA Microdialysis Piperazine Pharmacology +6

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.

Molecular Pharmacology June 2003 Vincent Setola, Sandra J Hufeisen, K Jane Grande-Allen et al.

Recent findings have implicated the 5-hydroxytryptamine 2B (5-HT2B) serotonin receptor in mediating the heart valve fibroplasia [valvular heart disease (VHD)] and primary pulmonary hypertension observed in patients taking the now-banned appetite suppressant fenfluramine (Pondimin, Redux). Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine...

Comparative Effects of Substituted Amphetamines (PMA, MDMA, and METH) on Monoamines in Rat Caudate

Annals of the New York Academy of Sciences June 1, 2002 B. Gough, Syed Z. Imam, Bruce E. Blough et al. 47 citations

A bstract : Paramethoxyamphetamine (PMA) is a methoxylated phenethylamine derivative that has been used illicitly in Australia since 1994. PMA is also becoming popular at rave parties in the United States. PMA raised concern when a series of fatalities resulted after its use in South Australia, where it was marketed as “ecstasy,” which is the colloquial name for MDMA. In the present study, we...